Navigation Links
Swedish Biotech Licenses HIV Drug to China for Development

The Swedish biotechnology company Medivir announced yesterday that it has licensed its experimental non-nucleoside// reverse transcriptase inhibitor (NNRTI), code-named MIV-160, to the Chinese company Guangdong Lantai Viewland Pharmaceutical for the China region. Medivir will retain the worldwide rights to the product.

Guangdong Lantai Viewland Pharmaceutical will potentially develop MIV-160 for three different products; an oral treatment regime, a vaginal microbicide and coating of condoms. It is the first antiretroviral product to be investigated as an additive agent to condom lubrication.

Professor Bo Oberg, head of the HIV franchise at Medivir, told aidsmap: 'This should enhance the safety of condoms and will at least save a few infections.'

MIV-160 is also an attractive microbicide product, he said, because it can inhibit HIV at very low concentrations – several thousand times lower than products currently being investigated in phase III trials in Africa. A second Medivir NNRTI – MIV-150 – is being investigated in combination with the microbicide Carraguard in a phase I study.

Medivir says that MIV-160, still in pre-clinical development, has shown good activity against NNRTI-resistant virus.

It is the first time that a Chinese company has won the global rights to develop an HIV product. Prof. Oberg said that Medivir will retain the right to commercialise or license any developments that result from the partnership for the rest of the world.

Medivir is also involved in two other development partnerships, with Tibotec for an HIV protease inhibitor and a nucleoside analogue, and with Bristol Myers Squibb for the NNRTI MIV-170.

Source-Bio-Bio Technology
SM
'"/>




Page: 1

Related medicine news :

1. Sick Swedish seagull was drunk, not affected by bird flu
2. GE Healthcare to Acquire Swedish Medical Company
3. Biotechnology industry expected to grow into a three billion dollar industry by 2002
4. Biotechnology on the lead
5. Panacea Biotech To Market Anthrax Vaccine
6. Commercialization of Biotech Discoveries, An Encouragement For Researchers
7. Biotech drug causing anemia-EPREX
8. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
9. Biologicals Transfer Proposal between US and Indian Biotechnology
10. Vical Biotech and NIH jointly develops HIV vaccine
11. Biotechnology Initiatives Planned In Hyderabad
Post Your Comments:
(Date:10/10/2008)...areful screening for these patients, researcher sa...-- Patients coping with metabolic syndrome have a ...ancer sometime in their lives, a new study suggest... three or four diseases, that together can portend...g a number of cancers," said study co-author Dr. D...
(Date:10/10/2008)...(NIH) scientists have identified a protein that pl...d cells, T and B cells, enabling them to interact ...ing immunity after an infection. Their finding ma...etic defect that prevents them from making this pr...a common virus that otherwise is rarely fatal (Eps...
(Date:10/10/2008)...e/ -- The Johns Hopkins University School,of Medic...ogram,"Optimizing Adjuvant Breast Cancer Strategi...esent recent key research data on the latest advan... advancements in the treatment of breast cancer ha...combinations that are,increasingly tailored to the...
(Date:10/10/2008)...nformation from PET to traditional CT and enable...d workflow efficiency and quick retu...swire/ -- Siemens Healthcare, (http://www.siemens....ncept in,integrated imaging that provides a premiu...r today,s shrinking healthcare budget. This new,te...
Breaking Medicine News(10 mins):Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 2Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 3Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...will not prevent chronic diseases in postmenopausa... found to increase // the risk of stroke and decre...est research. For the study investigators examined...ne or in combination with progestin would reduce c...
...study researchers say zinc supplements may increas...h attention deficit hyperactivity // disorder ( AD...tion of melatonin, which helps regulate dopamine f...HD and its treatment and researchers say dopamine,...
...e surgery, for colorectal cancer has been done on ... small // holes instead of the more conventional l...from a faster recovery with the laparoscopic proce...usly been studied. Laparoscopic surgery for colore...
... conducted a study to examine whether current proc...scribe antibiotics // unnecessarily. Out of an est... percent received antibiotic prescriptions. Doctor...rapid tests to detect streptococcus in children an...
Other Medicine News:
(Date:10/10/2008)...Prophylaxis Treatment with Kogenate FS Reduces the...ren with No Pre-Existing,Joint Damage, BERKELEY, ...LC,announced today that the U.S. Food and Drug Adm... with Kogenate(R) FS Antihemophilic Factor,(Recomb...s and the risk of,joint damage in patients aged 0-...
(Date:10/9/2008)...paign to Spread Awareness and Bring Hope to Millio...swire-USNewswire/ -- 133 million children,across t...uch as natural,disaster, civil war, and disease. S...World Orphan Week by calling attention to the need...ews Release, go to:, http://www.prnewswire.com/m...
(Date:10/9/2008)...nal Science Institute, Navigenics, Affymetrix and,...N DIEGO, Oct. 9 /- A consortium of he...ined forces in a first-of-its-kind,research study ...c testing,on people who choose to receive such scr...oping certain diseases., Sponsored by Scripps Tra...
(Date:10/8/2008)...eday Inform Treatments for Spinal Cord, Other Nerv...Newswire/ -- A protein that enables,nerve cells to...ontrolling,the developing nervous system. Research...o form among nerve cells may provide a basis for e...s to their nervous system,including spinal cord i...
Breaking Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Mom You Rock 21 17145 2/ 1Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4692 1Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4692 2Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4692 3Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4692 4Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4692 5Breast Feeding While on Seizure Meds Doesnt Harm Babies 17141 1Breast Feeding While on Seizure Meds Doesnt Harm Babies 17141 2Parents stricter with older kids to set example 3A game theory study 17136 1Parents stricter with older kids to set example 3A game theory study 17136 2
...earing in the March,22 New England Journal of Medi...tes of Healths National Institute of Arthritis and...scovered a,connection between a specific gene and ...as a possible host of autoimmune,diseases. , Vitil...he cells,that make pigment) in the skin are destro...
...tion management,programs, ST. PAUL, Minn., April 1...rime Therapeutics (Prime) today announced the resu...(atomoxetine) for treating,attention deficit hyper...und that children who start on Strattera were 4.2 ...ldren who started on,stimulants. Due to these resu...
Other Medicine Technology:Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 2Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 3Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: